Deloitte June 18, 2020
Felix Matthews, MD, MBA, managing director, and Ken Abrams, MD, MBA, managing director, Virtual Health Market Offering leader

Even before the COVID-19 pandemic, 88 percent of health care providers had already invested in remote patient monitoring (RPM) or said they planned to do so in the future.1 In addition, a recent study conducted by the Deloitte Center for Health Solutions and the American Telemedicine Association found that 88 percent of health care executives predicted wearable devices would soon be integrated with care delivery—a clear derivative of consumer expectations for a tailored, hyper-personalized virtual health experience.

The reduced use of health care during the pandemic could drive greater adoption of RPM. For example, chronically ill patients who put off routine care during the pandemic could see their conditions worsen. RPM can be used to monitor and manage many chronic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Big Data, Digital Health, Health IT, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Technology, Telehealth, Wearables
Your Earphones And Headphones As Health And Medical Devices
Wearable Devices for Parkinson’s Disease: The Future Is Here
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Amwell’s Roy Schoenberg talks about telehealth and broader views of virtual care
AI Translates Nature into New Medicines | StartUp Health Insights: Week of Nov 26, 2024

Share This Article